Title of article
Effect of dexmedetomidine added to spinal bupivacaine for urological procedures
Author/Authors
Al-Mustafa, Mahmoud M. Jordan University Hospital - Department of Anesthesia and Intensive Care, Jordan , Abu-Halaweh, Sami A. Jordan University Hospital - Department of Anesthesia and Intensive Care, Jordan , Aloweidi, AbdelKarim S. Jordan University Hospital - Department of Anesthesia and Intensive Care, Jordan , Murshidi, Mujalli M. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Ammari, Bassam A. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Awwad, Ziad M. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Al-Edwan, Ghazi M. Jordan University Hospital - Urology Unit - Department of Special Surgery, Jordan , Ramsay, Micheal A. Baylor University - Medical Center - Department of Anesthesiology Pain Management, USA
From page
365
To page
370
Abstract
Objectives: To determine the effect of adding dexmedetomidine to bupivacaine for neuraxial anesthesia. Methods: Sixty-six patients were studied between April and May 2008 in the University of Jordan, Amman Jordan. They were randomly assigned into 3 groups, each receiving spinal bupivacaine 12.5mg combined with normal saline (group N) Dexmedetomidine 5μg (group D5), or dexmedetomidine 10μg (group D10). The onset times to reach T10 sensory and Bromage 3 motor block, and the regression times to reach S1 sensory level and Bromage 0 motor scale, were recorded. Results: The mean time of sensory block to reach the T10 dermatome was 4.7±2.0 minutes in D10 group, 6.3±2.7 minutes in D5, and 9.5±3.0 minutes in group N. The mean time to reach Bromage 3 scale was 10.4±3.4 minutes in group D10, 13.0±3.4 minutes in D5, and 18.0±3.3 minutes in group N. The regression time to reach S1 dermatome was 338.9±44.8 minutes in group D10, 277.1±23.2 minutes in D5, and 165.5±32.9 minutes in group N. The regression to Bromage 0 was 302.9±36.7 minutes in D10, 246.4±25.7 minutes in D5, and 140.1±32.3 minutes in group N. Onset and regression of sensory and motor block were highlysignificant (N vesus D5, N versus D10, and D5 versus D10, p 0.001). Conclusion: Dexmedetomidine has a dose dependant effect on the onset and regression of sensory and motor block when used as an adjuvant to bupivacaine in spinal anesthesia.
Journal title
Saudi Medical Journal
Journal title
Saudi Medical Journal
Record number
2680992
Link To Document